Moon Capital Management has decided to liquidate its holdings in DaVita, a prominent provider of kidney dialysis services, during the second quarter of 2026. This move comes after an initial acquisition of shares at approximately $72 per share, driven by a favorable valuation following a revised 2023 guidance. A core tenet of the investment strategy was DaVita's potential to enhance per-share value through aggressive share buybacks during a period of perceived undervaluation. However, the long-term growth outlook for DaVita has become increasingly complex. Despite decades of expansion, the total volume of dialysis treatments has remained largely stagnant over the past six years, presenting significant headwinds for future business growth and profitability.
Moon Capital Management Divests DaVita Position Due to Evolving Market Conditions
In a strategic portfolio adjustment, Moon Capital Management concluded its investment in DaVita (DVA) during the second quarter of 2026. The original rationale for acquiring DaVita shares, which occurred around the $72 mark, was primarily rooted in the company's attractive valuation subsequent to a downward revision of its 2023 financial projections. A central element of Moon Capital's investment thesis was the expectation that DaVita could leverage its then-depressed stock price to initiate substantial share repurchase programs, thereby significantly boosting per-share value for investors. This approach aimed to capitalize on what was seen as an opportunity for robust capital allocation in a undervalued entity. However, subsequent market developments and a closer examination of industry trends indicated a more challenging landscape for DaVita's long-term expansion. The dialysis treatment sector, after an extended period of robust growth, has observed a plateau in overall treatment volumes, which have remained relatively constant for the past six years. This stagnation, coupled with increasing operational costs and a slower pace of reimbursement growth relative to inflation, has cast a shadow on the company's future growth algorithm. Consequently, Moon Capital Management opted to exit its position, reallocating capital to opportunities with more favorable growth trajectories.
From an investor's standpoint, this decision highlights the critical importance of continuously reassessing investment theses in light of changing market and industry dynamics. While initial valuations and capital allocation strategies might appear compelling, factors such as market saturation, regulatory pressures, and macroeconomic trends can fundamentally alter a company's long-term prospects. The experience with DaVita underscores that even a fundamentally strong operator can face significant challenges when its core market matures and external factors impede growth. It serves as a reminder for investors to maintain vigilance and adapt their portfolios as underlying business environments evolve, prioritizing sustainable growth potential over past performance or temporary valuation discrepancies.
